The work will leverage ProBioGen’s CHO.RiGHT expression platform, powered by its proprietary DirectedLuck transposase technology, alongside PsiBot smart automation
Currently approved for patients eight and older, Tzield could now be used to delay the onset of stage 3 type 1 diabetes (T1D) in children diagnosed with stage 2 T1D
Heart failure affects an estimated 64.3 million people worldwide
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
Syrma Johari is a globally recognised medical device engineering and manufacturing organisation
Before this appointment, he served as the Secretary in the Department of Land Resources, Ministry of Rural Development
The portfolio, purchased from a leading multinational generic manufacturer, addresses a market valued at $473.2 million for the 12 months ending August 2025
The company’s consolidated revenue from operations rose to Rs. 361.13 crore in Q2 FY26 and Rs. 707.67 crore for the first half
The surgical team used LD Flap Reconstruction, a specialised technique that rebuilt elbow strength and movement
Subscribe To Our Newsletter & Stay Updated
